MedPath

Patient-Centered Implementation Trial for Single Embryo Transfer

Not Applicable
Completed
Conditions
Pregnancy
Male Infertility
Female Infertility
Interventions
Behavioral: evidence based decision aid
Behavioral: Possible reimbursement 4th IVF/ICSI cycle when necessary
Registration Number
NCT00315029
Lead Sponsor
Radboud University Medical Center
Brief Summary

Background: The number of multiple pregnancies is considered to be the most important adverse effect of in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI). IVF or ICSI with transferring only one embryo, elective single embryo transfer (eSET), will reduce this incidence remarkably. Unfortunately, former research has documented that cycles with SET maintain lower pregnancy rates compared to double embryo transfer (DET). Implementation of eSET will require a carefully chosen and thoroughly defined implementation strategy focussed on the couple undergoing the subfertility treatment. This trial will investigate the (cost)effectiveness of a combined patient centred implementation strategy.

Objective: The main aim is to compare the effectiveness and costs of implementation of elective single embryo transfer (eSET) in in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI), between usual care and a combined patient-centred strategy.

Study design: A randomised controlled trial

Study population: Couples with a female age less than 40 years ongoing an IVF/ICSI treatment in 2 of the 13 Dutch IVF centres and their 4 satellite/transport centres.

Intervention A combined patient centred implementation strategy for eSET in IVF/ICSI. The strategy consists of counselling through an evidence based decision aid and reimbursement of a 4th cycle if couples have chosen for eSET in the first 2 cycles.

Primary study parameters/outcome of the study: the eSET occurrence rate, pregnancy outcomes and cost-effectiveness of the combined strategy.

Secondary study parameters/outcome of the study:

* patient knowledge

* patient decisional conflict

* patient satisfaction

* IVF/ICSI treatment outcome.

Detailed Description

see above

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
230
Inclusion Criteria
  • Female age < 39 years
  • In first cycle minimum of two embryos available for transfer
Exclusion Criteria
  • Medical necessity for single embryo transfer

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1evidence based decision aidReceives combined patient centred intervention
1Possible reimbursement 4th IVF/ICSI cycle when necessaryReceives combined patient centred intervention
Primary Outcome Measures
NameTimeMethod
Incidence choice for eSETafter embryo transfer
Secondary Outcome Measures
NameTimeMethod
Patient experiencesduringg treatment
patient decisional conflictduring treatment
Patient knowledgeduring treatment
Pregnancy outcomesafter treatment
Cost-effectivenessafter follow up

Trial Locations

Locations (2)

Radboud University Nijmegen Medical Centre

🇳🇱

Nijmegen, Netherlands

Catharina ziekenhuis Eindhoven

🇳🇱

Eindhoven, Netherlands

© Copyright 2025. All Rights Reserved by MedPath